We are live on ! Find out more
AMPH icon

Amphastar Pharmaceuticals
AMPH

92 hedge funds and large institutions have $160M invested in Amphastar Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 37 increasing their positions, 23 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 23

58% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 12

8% more funds holding

Funds holding: 85 → 92 (+7)

31% less capital invested

Capital invested by funds: $234M → $160M (-$73.4M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $9K

Holders
92
Holders Change
+7
Holders Change %
+8.24%
% of All Funds
2.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
37
Reduced
23
Closed
12
Calls
–
Puts
$9K
Net Calls
-$9K
Net Calls Change
-$290K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$4.38M
2
Fisher Asset Management
Fisher Asset Management
Washington
+$3.48M
3
SAMC
Shinko Asset Management Company
Japan
+$3.48M
4
Northern Trust
Northern Trust
Illinois
+$3.25M
5
BIT
BlackRock Institutional Trust
California
+$2.66M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$7.88M
2
KCM
Kingdon Capital Management
New York
-$3.63M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$3.04M
4
Renaissance Technologies
Renaissance Technologies
New York
-$2.79M
5
Two Sigma Investments
Two Sigma Investments
New York
-$2.65M
Name Holding Trade Value Shares
Change 		Change in
Stake
Acadian Asset Management
51
Acadian Asset Management
Massachusetts
$340K +$437K +29,153 New
AllianceBernstein
52
AllianceBernstein
Tennessee
$336K +$55.5K +3,700 +15%
Deutsche Bank
53
Deutsche Bank
Germany
$316K -$2.29M -152,727 -85%
AQR Capital Management
54
AQR Capital Management
Connecticut
$283K +$363K +24,170 New
MLICM
55
Metropolitan Life Insurance Company (MetLife)
New York
$263K -$12.6K -841 -4%
DekaBank Deutsche Girozentrale
56
DekaBank Deutsche Girozentrale
Germany
$263K +$12K +800 +4%
RFC
57
Russell Frank Company
Washington
$252K -$1.22M -81,296 -79%
Bank of Montreal
58
Bank of Montreal
Ontario, Canada
$248K +$58.2K +3,880 +22%
PCM
59
Prelude Capital Management
New York
$246K +$316K +21,078 New
ARTA
60
A.R.T. Advisors
New York
$230K +$296K +19,720 New
AIG
61
American International Group
New York
$218K +$330 +22 +0.1%
D.E. Shaw & Co
62
D.E. Shaw & Co
New York
$202K -$212K -14,110 -45%
ACI
63
AMP Capital Investors
Australia
$196K +$272K +18,142 New
PPA
64
Parametric Portfolio Associates
Washington
$187K +$240K +16,009 New
VKH
65
Virtu KCG Holdings
New York
$178K +$229K +15,263 New
BA
66
BlackRock Advisors
Delaware
$176K -$12.8K -851 -5%
VOYA Investment Management
67
VOYA Investment Management
Georgia
$169K – – –
Barclays
68
Barclays
United Kingdom
$156K +$202K +13,452 +1,922%
RCM
69
Rotella Capital Management
Washington
$152K +$195K +13,012 New
GCP
70
GSA Capital Partners
United Kingdom
$146K +$187K +12,486 New
AIM
71
Ada Investment Management
New York
$116K +$152K +10,109 New
FCE
72
Fiera Capital (Europe)
Cayman Islands
$98K – – –
BGIM
73
Brandywine Global Investment Management
Pennsylvania
$93K – – –
Wells Fargo
74
Wells Fargo
California
$88K +$6.2K +413 +6%
BG
75
BlackRock Group
United Kingdom
$87K +$26.4K +1,759 +31%
1 2
3
4 5

AMPH Hedge Fund Activity: Q3 2015 in Review

92 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Amphastar Pharmaceuticals (AMPH) for Q3 2015, worth a combined $160M — down 31% from $234M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new AMPH positions and 12 closed out — a net gain of 7 holders — while 37 added to existing stakes and 23 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $4.38M. The largest seller was Deerfield Management, exiting entirely with an estimated $7.88M sold.

  • 92 institutional investors held Amphastar Pharmaceuticals (AMPH) as of Q3 2015, up from 85 in Q2 2015.
  • Funds reported $160M of Amphastar Pharmaceuticals stock for Q3 2015, down 31% quarter-over-quarter.
  • 19 funds opened new Amphastar Pharmaceuticals positions in Q3 2015 and 12 closed out, a net change of +7 holders.
  • The largest Amphastar Pharmaceuticals buyer in Q3 2015 was Fidelity Investments, an estimated $4.38M added.
  • The largest Amphastar Pharmaceuticals seller in Q3 2015 was Deerfield Management, an estimated $7.88M sold.

Based on aggregated 13F filings for Q3 2015.